Funding for this research was provided by:
the Japan Society for the Promotion of Science (15H05721, 15H05721)
Received: 14 July 2022
Accepted: 11 January 2023
First Online: 20 January 2023
: The animal study was approved by the Kyoto University Graduate School of Medicine, and conducted following Guidelines for Proper Conduct of Animal Experiments (Science Council of Japan). Experimental procedures of this study were in accordance with ARRIVE guidelines.
: Not applicable.
: M.H. is a shareholder and member of the scientific advisory board of KinoPharma, Inc. The other authors have no competing interests to disclose.